NO | Ibicuruzwa | CAS OYA | Gusaba | Ikimenyetso Cyingenzi | ||||
Ubuziranenge | Isomer | Umwanda wihariye | * Max1 | Ubuhehere | ||||
1 | FMOC-CSS (ACM) -Oh | 86060-81-3 | Dend | ≥99.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
2 | FMOC-CSS (MMT) -Oh | 177582-21-7 | Dend | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
3 | FMOC-CSS (4-AllyByrate) -Oh | / | Dend | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
4 | MPA (TRT) -Oh | 27144-18-9-9 | Iherezo ryurutonde | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
5 | FMOC-THR (TBU) -Ol | 189337-28-8 | Octreotide | ≥97.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
6 | FMOC-D-ARG (PBF) -Oh | 187618-60-6 | Desmopressin | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
7 | FMOC-GLY-GLY-OH | 35665-38-4 | Birwalirudin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
8 | FMOC-GLY-GLY-GLY-OH | 170941-79-4 | Terlipressin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
9 | FMOC-GLY-GLY-GLY-RLY-OH | / | Birwalirudin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
10 | FMOC-GLY-ASP (TBU) -Oh | / | Birwalirudin | ≥99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
11 | Boc-cys (TRT) -Oh | 21947-98-8-8-8 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
12 | Boc-arg (pbf) -oh | 200124-22-7 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
13 | Boc-ala-yewe | 15761-38-3 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
14 | Boc-d-phe-oh | 18942-49-9 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
15 | Boc-gly-oh | 4530-20-5 | Iherezo ryurutonde | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
16 | Boc-lys (boc) -ohdddcha | 15098-69-8 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
17 | Boc-Ser (TBU) -Oh | 7738-22-9 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
18 | Boc-Th (TBU) -Oh | 13734-40-2 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
19 | Boc-D-Ala-OH | 7764-95-6 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
20 | Boc-Rusange-Oh | 248-15-5 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
21 | Boc-Ty (TBU) -Oh | 47375-34-8 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
22 | Boc-d-arg (pdf) -oh | 187618-60-6 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
23 | Boc-asp (otbu) -Ohdddcha | 1913/12/8 | Iherezo ryurutonde | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
24 | FMOC-HOMOARG (PBF) -Oh | 1159680-21-3 | EptifibaTide | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
25 | FMOC-ASP-OTBU | 129460-09-9 | Thymasin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
26 | FMOC-TR (NJYE) -OH | 77128-72-4 | Carbetocine | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
27 | FMOC-ORN (BOC) -Oh | 10942555-0 | Atosiban Omnipressin Daptomycin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
28 | FMOC-D-TRR (et) -Oh | 162502-65-0 | Atosiban | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
29 | Fmoc-asp (oall) -Oh | 146982-24-3 | Melanotan | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
30 | Ac-nle-oh | 15891-49-3 | Melanotan | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
31 | FMOC-NLE-OH | 77284-32-3 | Melanotan Afamelanotide | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
32 | AC-GLU (OTBU) -Oh | 84192-88-1 | Argitwari Acetyl Octapptide-3 | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
33 | AC-β-ala-oh · dcha | / | Acetyl tetrapeptide-5 | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
34 | FMOC-ß-ALO-OH | 35737-10-1 | Acetyl tetrapeptide-5 | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
35 | FMOC-HYP (TBU) -Oh | 122996-47-8 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
36 | Fmoc-thi-oh | 130309-35-25-35-2 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
37 | FMOC-D-Tic-Oh | 130309-33-0 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
38 | FMOC-OIC-OH | 130309-37-4 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
39 | Boc-sar-oh | 13734-36-6 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
40 | FMOC-SAR-OH | 77128-70-2 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
41 | FMOC-TR (TO3NA) -Oh.h.h2o | 106864-37-3 | Sincalide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
42 | FMOC-D-ASP (OTBU) -Oh | 112883-39-3 | Daptomycin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
43 | Ac-ser (TBU) -Oh | 77285-09-7 | Afamelanotide | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
44 | Boc-Homocys (TRT) -Oh | 201419-16-1 | Depiteotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
45 | FMOC-HOMOCYS (TRT) -Oh | 167015-23-8 | Depiteotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
46 | FMOC-DAB-OH | 161420-87-7 | Inzoka | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
* Max1 = Igitangaza kitazwi
Ikindi kimenyetso:
- acide ya acetike: ≤0.02% (ibicuruzwa byose)
- Ethyl Acetate: ≤0.5% (ibicuruzwa byose)
- Inzoga: ≤0.5% (ibicuruzwa byose)
- Umwanda wa Max Utazwi: FMOC-TR (Boc) -Oh (143824-78-6) ≤0.3%; Abandi ≤0.2%